INS and type 1 diabetes mellitus: Sofrà and Beer [102] first reported the case of a 32-year-old woman with overweight and a 20-year history of T1D, who was treated with a patch insulin pump and was prescribed semaglutide as non-insulin adjunct therapy to improve glucose control, reduce glycemic variability and counteract weight gain.